| Next 10 |
Ad
EKSO News and Press Ekso Bionics Holdings Inc.
-
Broadens Ekso Bionics’ product portfolio into home use Adds Vanderbilt University as a key commercial and research partner Acquisition consolidates leading lower extremity robotic companies Ekso President and COO Scott Davis promoted to Chief Executive Officer; St...
-
Ekso Bionics Holdings, Inc. (EKSO) Q3 2022 Earnings Conference Call November 3, 2022 16:30 ET Company Participants Matt Steinberg - Investor Relations Steven Sherman - Chairman and Chief Executive Officer Scott Davis - President and Chief Operating Officer Je...
-
Ekso Bionics Holdings press release ( NASDAQ: EKSO ): Q3 GAAP EPS of -$0.33. Revenue of $3.3M. For further details see: Ekso Bionics Holdings GAAP EPS of -$0.33, revenue of $3.3M
-
Quarterly Record of 33 EksoNR Bookings in Q3 2022 SAN RAFAEL, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial res...
-
SAN RAFAEL, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quar...
-
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, President and Chief Operating Officer, will be pres...
-
Summary Ekso Bionics has added a new use case for the EksoNR exoskeleton, multiple sclerosis, opening some new avenues for marginal revenue growth. Pre-Covid, Ekso had started to see sharp improvements in operating margins, but that trend came to a clear stop over the last two yea...
-
Ekso Bionics Holdings, Inc. (EKSO) Q2 2022 Results Conference Call July 28, 2022 04:30 PM ET Company Participants David Carey - Head, Investor Relations Steven Sherman - Chairman & CEO Scott Davis - President & Chief Operating Officer Jerome Wong - in...
-
Ekso Bionics Holdings press release ( NASDAQ: EKSO ): Q2 GAAP EPS of -$0.23 beats by $0.01 . Revenue of $3.5M (+59.1% Y/Y) beats by $0.01M . Booked a total of 17 EksoNR units in the second quarter of 2022. CEO comment: "Looking ahead, with increasing custom...
-
RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2022. Recen...
Stock Information
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Get EKSO Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
